| NCT Number | NCT05780359 |
| Lead Sponsor | Shenzhen Salubris Pharmaceuticals Co., Ltd.
Collaborators: Changhai Hospital |
| Conditions | Peripheral Artery Disease |
| Enrollment | 280 participants |
| Start Date | 2022-05-27 |
| Primary Completion | 2025-06-30 (estimated) |
| Study Completion | 2026-08-31 (estimated) |
| Updated on ClinicalTrials.gov | 2023-03-22 |